DexCom (DXCM) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $68.95 -0.17%
Revenue Growth %: +11.2%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +11.2%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $769.6 million versus the consensus estimate of $751.74 million.
GUIDANCE:
DexCom sees Q4 2022 revenue of $2.88-2.91 billion, versus the consensus of $2.89 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts DexCom (DXCM) at Buy
- DexCom (DXCM) Reiterated at Buy by Benchmark as Revenue Forecast Raised
- William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
